Jilin Aodong Pharmaceutical Group Co 000623.SZ · CNY

Its shares trade on Shenzhen under the ticker 000623.SZ. It has been listed since 28 October 1996. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.34bn and net income of CN¥2.40bn. At that date it held total assets of CN¥34.42bn and shareholders' equity of CN¥30.67bn.

Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing. The company is headquartered in Yanbian, Jilin. The Company’s main products include capsules, granules, oral liquid, tablets, ointments, powder, syrup, pills, medicated wine and herbal decoction pieces, among others. The firm is also involved in the production of health food and food, as well as breeding, planting and other businesses. The firm mainly distributes its products in domestic market.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Xiulin LiChairman of the Board, since 2000CN¥3.2m
• Ms. Shuqin GuoVice Chairman of the Board, General Manager, since 2000CN¥2.6m
• Ms. Shuyuan ZhangChief Financial Officer, Deputy General Manager, Director, since 2007CN¥785,100
• Mr. Zhenyu WangDeputy General Manager, Secretary of the Board, Director, since 2017CN¥735,100
• Mr. Kai YangDeputy General Manager, Director, since 2004CN¥805,100
• Mr. Xiaolin LinDeputy General ManagerCN¥335,100
• Mr. Dalong ZhaoDirectorCN¥735,100
• Mr. Peng LiIndependent DirectorCN¥132,500
• Mr. Biming LiangIndependent DirectorCN¥60,000
• Ms. Weiwei XiaoIndependent DirectorCN¥132,500

Overall

40

Environment

38

Social

22

Governance

59

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.